BDNF and depressive symptom measurement: On the other hand, the direct correlation of the mRNA substrate diminution after extended corticosterone presence (12 and 24 h) to the significant decrease in mBDNF protein in astrocytes is consistent with studies describing reduced BDNF levels in patients with major depressive disorder [34], as well as in animal models of depression [35,36].